DNA methylome and transcriptome profiling reveal key electrophysiology and immune dysregulation in hypertrophic cardiomyopathy

References

• Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92:785–17.
   PubMed Web of Science ®Google Scholar
• Marian AJ, Braunwald E. Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res. 2017;121:749–770.
   PubMed Web of Science ®Google Scholar
• Marian AJ. Molecular genetic basis of hypertrophic cardiomyopathy. Circ Res. 2021;128:1533–1553.
   PubMed Web of Science ®Google Scholar
• Ranjbarvaziri S, Kooiker KB, Ellenberger M, et al. Altered cardiac energetics and mitochondrial dysfunction in hypertrophic cardiomyopathy. Circulation. 2021;144:1714–1731.
   PubMed Web of Science ®Google Scholar
• Becker RC, Owens AP 3rd, Sadayappan S. Tissue-level inflammation and ventricular remodeling in hypertrophic cardiomyopathy. J Thromb Thrombolysis. 2020;49:177–183.
   PubMed Web of Science ®Google Scholar
• Litviňuková M, Talavera-López C, Maatz H, et al. Cells of the adult human heart. Nature. 2020;588:466–472.
   PubMed Web of Science ®Google Scholar
• Frieler RA, Mortensen RM. Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling. Circulation. 2015;131:1019–1030.
   PubMed Web of Science ®Google Scholar
• Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res. 2016;119:91–112.
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res. 2012;110:159–173.
   PubMed Web of Science ®Google Scholar
• Hulsmans M, Clauss S, Xiao L, et al. Macrophages facilitate electrical conduction in the heart. Cell. 2017;169:510–22.e20.
   PubMed Web of Science ®Google Scholar
• Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol. 2005;45:629–656.
   PubMed Web of Science ®Google Scholar
• Weber M, Davies JJ, Wittig D, et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet. 2005;37:853–862.
   PubMed Web of Science ®Google Scholar
• Aran D, Toperoff G, Rosenberg M, et al. Replication timing-related and gene body-specific methylation of active human genes. Hum Mol Genet. 2011;20:670–680.
   PubMed Web of Science ®Google Scholar
• Weber M, Hellmann I, Stadler MB, et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet. 2007;39:457–466.
   PubMed Web of Science ®Google Scholar
• Wu X, Zhang Y. TET-mediated active DNA demethylation: mechanism, function and beyond. Nat Rev Genet. 2017;18:517–534.
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhang Y. Role of mammalian DNA methyltransferases in development. Annu Rev Biochem. 2020;89:135–158.
   PubMed Web of Science ®Google Scholar
• Gilsbach R, Preissl S, Grüning BA, et al. Dynamic DNA methylation orchestrates cardiomyocyte development, maturation and disease. Nat Commun. 2014;5:5288.
   PubMed Web of Science ®Google Scholar
• Hoff K, Lemme M, Kahlert AK, et al. DNA methylation profiling allows for characterization of atrial and ventricular cardiac tissues and hiPSC-CMs. Clin Epigenetics. 2019;11:89.
   PubMed Web of Science ®Google Scholar
• Madsen A, Höppner G, Krause J, et al. An important role for DNMT3A-Mediated DNA methylation in cardiomyocyte metabolism and contractility. Circulation. 2020;142:1562–1578.
   PubMed Web of Science ®Google Scholar
• Laugier L, Frade AF, Ferreira FM, et al. Whole-genome cardiac DNA methylation fingerprint and gene expression analysis provide new insights in the pathogenesis of chronic Chagas disease cardiomyopathy. Clin Infect Dis. 2017;65:1103–1111.
   PubMed Web of Science ®Google Scholar
• Haider S, Cordeddu L, Robinson E, et al. The landscape of DNA repeat elements in human heart failure. Genome Biol. 2012;13:R90.
   PubMed Web of Science ®Google Scholar
• Movassagh M, Choy MK, Knowles DA, et al. Distinct epigenomic features in end-stage failing human hearts. Circulation. 2011;124:2411–2422.
   PubMed Web of Science ®Google Scholar
• Peters FS, Manintveld OC, Betjes MG, et al. Clinical potential of DNA methylation in organ transplantation. J Heart Lung Transplant. 2016;35:843–850.
   PubMed Web of Science ®Google Scholar
• Vasco M, Benincasa G, Fiorito C, et al. Clinical epigenetics and acute/chronic rejection in solid organ transplantation: an update. Transplant Rev (Orlando). 2021;35:100609.
   PubMedGoogle Scholar
• Sabia C, Picascia A, Grimaldi V, et al. The epigenetic promise to improve prognosis of heart failure and heart transplantation. Transplantation Rev. 2017;31:249–256.
   Web of Science ®Google Scholar
• Haas J, Frese KS, Park YJ, et al. Alterations in cardiac DNA methylation in human dilated cardiomyopathy. EMBO Mol Med. 2013;5:413–429.
   PubMed Web of Science ®Google Scholar
• Stenzig J, Hirt MN, Löser A , et al. DNA methylation in an engineered heart tissue model of cardiac hypertrophy: common signatures and effects of DNA methylation inhibitors. 2016;111(1):9.
   Google Scholar
• Glezeva N, Moran B, Collier P, et al. Targeted DNA methylation profiling of human cardiac tissue reveals novel epigenetic traits and gene deregulation across different heart failure patient subtypes. 2019;12(3):e005765.
   Google Scholar
• Pepin ME, Drakos S, Ha CM, et al. DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failure. Am J Physiol Heart Circ Physiol. 2019;317:H674–h84.
   PubMed Web of Science ®Google Scholar
• Mansueto G, Benincasa G, Della Mura N, et al. Epigenetic-sensitive liquid biomarkers and personalised therapy in advanced heart failure: a focus on cell-free DNA and microRnas. J Clin Pathol. 2020;73:535–543.
   PubMed Web of Science ®Google Scholar
• Shridhar K, Walia GK, Aggarwal A, et al. DNA methylation markers for oral pre-cancer progression: a critical review. Oral Oncol. 2016;53:1–9.
   PubMed Web of Science ®Google Scholar
• Hu X, Estecio MR, Chen R, et al. Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas. Nat Commun. 2021;12:687.
   PubMed Web of Science ®Google Scholar
• Jones PA, Ohtani H, Chakravarthy A, et al. Epigenetic therapy in immune-oncology. Nat Rev Cancer. 2019;19:151–161.
   PubMed Web of Science ®Google Scholar
• Mazzone R, Zwergel C, Artico M, et al. The emerging role of epigenetics in human autoimmune disorders. Clin Epigenetics. 2019;11:34.
   PubMed Web of Science ®Google Scholar
• Morales-Nebreda L, McLafferty FS, Singer BD. DNA methylation as a transcriptional regulator of the immune system. Transl Res. 2019;204:1–18.
   PubMed Web of Science ®Google Scholar
• Writing Committee M, Ommen SR, Mital S, et al. AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2020;162:e23–106.
   Web of Science ®Google Scholar
• McKenna A, Hanna M, Banks E, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–1303.
   PubMed Web of Science ®Google Scholar
• Dobin A, Davis CA, Schlesinger F, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21.
   PubMed Web of Science ®Google Scholar
• Yang H, Wang K. Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR. Nat Protoc. 2015;10:1556–1566.
   PubMed Web of Science ®Google Scholar
• Wu T, Hu E, Xu S, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (N Y). 2021;2:100141.
   PubMedGoogle Scholar
• Szklarczyk D, Gable AL, Nastou KC, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49:D605–d12.
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Andorf S, Gomes L, et al. ImmPort: disseminating data to the public for the future of immunology. Immunol Res. 2014;58:234–239.
   PubMed Web of Science ®Google Scholar
• Safran M, Rosen N, Twik M , et al. The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. Curr Protoc Bioinformatics. 2016; 54:1.30.1–1.30.33.
   Google Scholar
• Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220.
   PubMed Web of Science ®Google Scholar
• Chen T, Chen X, Zhang S, et al. The genome sequence archive family: toward explosive data growth and diverse data types. Genomics Proteomics Bioinf. 2021;19:578–583.
   PubMed Web of Science ®Google Scholar
• Mahmood N, Rabbani SA. DNA methylation readers and cancer: mechanistic and therapeutic applications. Front Oncol. 2019;9:489.
   PubMed Web of Science ®Google Scholar
• Gu Y, Liu GH, Plongthongkum N, et al. Global DNA methylation and transcriptional analyses of human ESC-derived cardiomyocytes. Protein Cell. 2014;5:59–68.
   PubMed Web of Science ®Google Scholar
• Hu C, Liu Y, Jiang S, et al. The variable association between expression and methylation of estrogen receptors and the survival of patients with different tumors. Clin Transl Med. 2020;10:e49.
   PubMed Web of Science ®Google Scholar
• Kovats S. Estrogen receptors regulate innate immune cells and signaling pathways. Cell Immunol. 2015;294:63–69.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Watanabe-Kominato K, Takahashi Y, et al. Adipose tissue-derived Omentin-1 function and regulation. Compr Physiol. 2017;7:765–781.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Watanabe R, Konii H, et al. Counteractive effects of omentin-1 against atherogenesis†. Cardiovasc Res. 2016;110:118–128.
   PubMed Web of Science ®Google Scholar
• Zheng L, Li S, Zheng X, et al. AHNAK2 is a novel prognostic marker and correlates with immune infiltration in papillary thyroid cancer: evidence from integrated analysis. Int Immunopharmacol. 2021;90:107185.
   PubMed Web of Science ®Google Scholar
• Zheng M, Liu J, Bian T, et al. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma. Int Immunopharmacol. 2021;90:107134.
   PubMed Web of Science ®Google Scholar
• Kimura I, Ichimura A, Ohue-Kitano R, et al. Free fatty acid receptors in health and disease. Physiol Rev. 2020;100:171–210.
   PubMed Web of Science ®Google Scholar
• Lymperopoulos A, Suster MS, Borges JI. Short-chain fatty acid receptors and cardiovascular function. Int J Mol Sci. 2022;23:3303.
   PubMed Web of Science ®Google Scholar
• Maslowski KM, Vieira AT, Ng A, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009;461:1282–1286.
   PubMed Web of Science ®Google Scholar
• Gao W, Wen H, Liang L, et al. IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer. Theranostics. 2021;11:2564–2580.
   PubMed Web of Science ®Google Scholar
• Ungaro F, Garlatti V, Massimino L, et al. MTOR-Dependent stimulation of IL20RA orchestrates immune cell trafficking through lymphatic endothelium in patients with Crohn’s disease. Cells. 2019;8:924.
   PubMed Web of Science ®Google Scholar
• D’amore PA, Alcaide P. Macrophage efferocytosis with VEGFC and lymphangiogenesis: rescuing the broken heart. J Clin Invest. 2022;132.
   PubMed Web of Science ®Google Scholar
• Glinton KE, Ma W, Lantz C, et al. Macrophage-produced VEGFC is induced by efferocytosis to ameliorate cardiac injury and inflammation. J Clin Invest. 2022;132.
   PubMed Web of Science ®Google Scholar
• Nordmeyer J, Eder S, Mahmoodzadeh S, et al. Upregulation of myocardial estrogen receptors in human aortic stenosis. Circulation. 2004;110:3270–3275.
   PubMed Web of Science ®Google Scholar
• Puzianowska-Kuźnicka M. ESR1 in myocardial infarction. Clin Chim Acta. 2012;413:81–87.
   PubMed Web of Science ®Google Scholar
• Matsuo K, Shibata R, Ohashi K, et al. Omentin functions to attenuate cardiac hypertrophic response. J Mol Cell Cardiol. 2015;79:195–202.
   PubMed Web of Science ®Google Scholar
• Shibata R, Ouchi N, Ito M, et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med. 2004;10:1384–1389.
   PubMed Web of Science ®Google Scholar
• Lee SH, Kim J, Ryu JY, et al. Transcription coactivator Eya2 is a critical regulator of physiological hypertrophy. J Mol Cell Cardiol. 2012;52:718–726.
   PubMed Web of Science ®Google Scholar
• Lee SH, Yang DK, Choi BY, et al. The transcription factor Eya2 prevents pressure overload-induced adverse cardiac remodeling. J Mol Cell Cardiol. 2009;46:596–605.
   PubMed Web of Science ®Google Scholar
• El-Sammak H, Yang B, Guenther S, et al. A Vegfc-Emilin2a-Cxcl8a signaling axis required for Zebrafish cardiac regeneration. Circ Res. 2022;130:1014–1029.
   PubMed Web of Science ®Google Scholar
• Li H, Trager LE, Liu X, et al. lncExact1 and DCHS2 regulate physiological and pathological cardiac growth. Circulation. 2022;145:1218–1233.
   PubMed Web of Science ®Google Scholar
• Johnson BD, Zheng W, Korach KS, et al. Increased expression of the cardiac L-type calcium channel in estrogen receptor-deficient mice. J Gen Physiol. 1997;110:135–140.
   PubMed Web of Science ®Google Scholar
• Kise Y, Kasuya G, Okamoto HH, et al. Structural basis of gating modulation of Kv4 channel complexes. Nature. 2021;599:158–164.
   PubMed Web of Science ®Google Scholar
• Tsai CT, Hsieh CS, Chang SN, et al. Genome-wide screening identifies a KCNIP1 copy number variant as a genetic predictor for atrial fibrillation. Nat Commun. 2016;7:10190.
   PubMed Web of Science ®Google Scholar
• Christophersen IE, Olesen MS, Liang B, et al. Genetic variation in KCNA5: impact on the atrial-specific potassium current IKur in patients with lone atrial fibrillation. Eur Heart J. 2013;34:1517–1525.
   PubMed Web of Science ®Google Scholar
• Yang T, McBride BF, Leake BF, et al. Modulation of drug block of the cardiac potassium channel KCNA5 by the drug transporters OCTN1 and MDR1. Br J Pharmacol. 2010;161:1023–1033.
   PubMed Web of Science ®Google Scholar
• Komuro A, Masuda Y, Kobayashi K, et al. The AHNAKs are a class of giant propeller-like proteins that associate with calcium channel proteins of cardiomyocytes and other cells. Proc Natl Acad Sci U S A. 2004;101:4053–4058.
   PubMed Web of Science ®Google Scholar
• Martini E, Kunderfranco P, Peano C, et al. Single-cell sequencing of mouse heart immune infiltrate in pressure overload-driven heart failure reveals extent of immune activation. Circulation. 2019;140:2089–2107.
   PubMed Web of Science ®Google Scholar
• Locati M, Curtale G, Mantovani AD. Mechanisms, and significance of macrophage plasticity. Annu Rev Pathol. 2020;15:123–147.
   PubMed Web of Science ®Google Scholar
• Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010;32:593–604.
   PubMed Web of Science ®Google Scholar
• Heyn H, Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet. 2012;13:679–692.
   PubMed Web of Science ®Google Scholar
• Ward MC, Banovich NE, Sarkar A, et al. Dynamic effects of genetic variation on gene expression revealed following hypoxic stress in cardiomyocytes. Elife. 2021;10.
   Web of Science ®Google Scholar
• Villicaña S, Bell JT. Genetic impacts on DNA methylation: research findings and future perspectives. Genome Biol. 2021;22:127.
   PubMed Web of Science ®Google Scholar
• Majewski J, Pastinen T. The study of eQTL variations by RNA-seq: from SNPs to phenotypes. Trends Genet. 2011;27:72–79.
   PubMed Web of Science ®Google Scholar
• Cohn R, Thakar K, Lowe A, et al. A contraction stress model of hypertrophic cardiomyopathy due to sarcomere mutations. Stem Cell Rep. 2019;12:71–83.
   PubMed Web of Science ®Google Scholar
• Yotti R, Seidman CE, Seidman JG. Advances in the genetic basis and pathogenesis of sarcomere cardiomyopathies. Annu Rev Genomics Hum Genet. 2019;20:129–153.
   PubMed Web of Science ®Google Scholar
• Lehman SJ, Tal-Grinspan L, Lynn ML, et al. Chronic Calmodulin-Kinase II activation drives disease progression in mutation-specific hypertrophic cardiomyopathy. Circulation. 2019;139:1517–1529.
   PubMed Web of Science ®Google Scholar
• Nicolás-Ávila JA, Lechuga-Vieco AV, Esteban-Martínez L, et al. A network of macrophages supports mitochondrial homeostasis in the heart. Cell. 2020;183:94–109.e23.
   PubMed Web of Science ®Google Scholar
• Um E, Oh JM, Park J, et al. Immature dendritic cells navigate microscopic mazes to find tumor cells. Lab Chip. 2019;19:1665–1675.
   PubMed Web of Science ®Google Scholar
• Pistulli R, König S, Drobnik S, et al. Decrease in dendritic cells in endomyocardial biopsies of human dilated cardiomyopathy. Eur J Heart Fail. 2013;15:974–985.
   PubMed Web of Science ®Google Scholar
• Mahmoodzadeh S, Eder S, Nordmeyer J, et al. Estrogen receptor alpha up-regulation and redistribution in human heart failure. Faseb J. 2006;20:926–934.
   PubMed Web of Science ®Google Scholar
• Gavin KM, Seals DR, Silver AE, et al. Vascular endothelial estrogen receptor alpha is modulated by estrogen status and related to endothelial function and endothelial nitric oxide synthase in healthy women. J Clin Endocrinol Metab. 2009;94:3513–3520.
   PubMed Web of Science ®Google Scholar
• Grohé C, Kahlert S, Löbbert K, et al. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett. 1997;416:107–112.
   PubMed Web of Science ®Google Scholar
• Hutson DD, Gurrala R, Ogola BO, et al. Estrogen receptor profiles across tissues from male and female Rattus norvegicus. Biol Sex Differ. 2019;10:4.
   PubMed Web of Science ®Google Scholar
• Lin AL, Schultz JJ, Brenner RM, et al. Sexual dimorphism characterizes baboon myocardial androgen receptors but not myocardial estrogen and progesterone receptors. J Steroid Biochem Mol Biol. 1990;37:85–95.
   PubMed Web of Science ®Google Scholar
• Meyer S, van der Meer P, van Tintelen JP, et al. Sex differences in cardiomyopathies. Eur J Heart Fail. 2014;16:238–247.
   PubMed Web of Science ®Google Scholar
• Nijenkamp L, Bollen IAE, van Velzen HG, et al. Sex differences at the time of myectomy in hypertrophic cardiomyopathy. Circ Heart Fail. 2018;11:e004133.
   PubMed Web of Science ®Google Scholar
• Olivotto I, Maron MS, Adabag AS, et al. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;46:480–487.
   PubMed Web of Science ®Google Scholar
• Schuldt M, Dorsch LM, Knol JC, et al. Sex-related differences in protein expression in sarcomere mutation-positive hypertrophic cardiomyopathy. Front Cardiovasc Med. 2021;8:612215.
   PubMed Web of Science ®Google Scholar
• Deviatiiarov R, Gams A, Syunyaev R, et al. An atlas of transcribed human cardiac promoters and enhancers reveals an important role of regulatory elements in heart failure. Nature Cardiovascular ResearchNature Cardiovascular Research. 2023;2:58–75.
   Google Scholar